Medscape

Medscape InDiscussion: Esophageal Cancer

Science EN ↓ 6 Folgen

Listen to Medscape InDiscussion: Esophageal Cancer, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999882. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Autor

Medscape

Kategorie

Science

Podcast-Website

www.medscape.com

Neueste Folge

29. Okt 2024

Wo hören?

Podcasts in der App Replaio Radio Bald verfügbar

Podcasts kommen bald in die App. Installiere sie jetzt und erlebe als Erster einen ganz neuen Blick auf Podcasts

Bei Google Play herunterladen Kostenlos installieren Android fast 10 Mio. Downloads · Bewertung 4,8 iOS bald

Folgen

ASCO 2024: What the ESOPEC, RENAISSANCE, and ARMANI Trials Mean for the Future of Esophageal Cancer Treatment 29.10.2024

Drs Samuel Klempner and Yelena Janjigian break down major takeaways from the clinical trial data presented at ASCO 2024. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999887. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Reso...

Emerging Biomarkers and Novel Therapies for Esophageal Cancer 26.09.2024

Drs Samuel Klempner and Haeseong Park discuss emerging biomarkers and novel therapies for esophageal cancer, including new data from ASCO. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999886. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare p...

Clinical Scenarios and Approaches to Treating Locally Advanced Esophageal Adenocarcinoma 28.08.2024

Drs Samuel Klempner and Nataliya Uboha discuss the treatment of patients with locally advanced esophageal adenocarcinomas who opt to not undergo esophagostomy. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999885. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended onl...

Navigating Esophageal Squamous Cell Cancer From Diagnosis to Treatment 30.07.2024

Drs Samuel Klempner and Geoffrey Ku deep dive into all things esophageal squamous cell cancer, including detection, staging, and treatment. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999884. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare...

Standard-of-Care, Second-Line, and Future Therapies for GEJ and Esophageal Adenocarcinoma 26.06.2024

Drs Samuel Klempner and Zev Wainberg discuss standard-of-care, second-line, and future therapies for GE junction, esophageal, and gastric cancers. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999883. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US heal...

Understanding, Detecting, and Treating Gastroesophageal Junction Adenocarcinoma 26.06.2024

Drs Samuel Klempner and Yelena Janjigian provide clinical pearls for understanding, detecting, and treating GEJ adenocarcinoma. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999882. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professional...

Höre den Podcast Medscape InDiscussion: Esophageal Cancer in Replaio

Radio und Podcasts in einer App - kostenlos und ohne Anmeldung. Installiere sie noch heute und verpasse den Start nicht

Bei Google Play herunterladen

Replaio ist kein Herausgeber von Podcasts; die Namen der Sendungen, Cover und Audioinhalte gehören ihren Autoren und werden über öffentliche RSS-Feeds verbreitet